NCT02678234View on ClinicalTrials.gov

An Efficacy and Safety Study of Theraflu Day Powder as Oral Solution for Cold and Flu

PHASE3WithdrawnINTERVENTIONAL

0

Timeline

Start Date

February 1, 2017

Primary Completion Date

April 1, 2017

Study Completion Date

April 1, 2017

Conditions

Infections, Respiratory Tract

Interventions

DRUG

Paracetamol, phenylephrine HCl, and vitamin C

One sachet is provided for each participant randomized to the Theraflu Aktiv powder for oral solution

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY